Pfizer, BioNTech Hit Pause On COVID Shot Trial As Enrollment Falls Flat

Pfizer & BioNTech halt recruitment for a major U.S. COVID vaccine trial for adults 50–64 due to low enrollment. Read the latest updates. Importance Rank: 1 read more

Go to News Site